Navigation Links
FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): TGF-β Superfamily: Signaling in Development and Disease.

The 2013 "TGF-β Superfamily: Signaling in Development and Disease" is an important and unique scientific conference where the pivotal role of TGF- family members in developmental and homeostatic processes is explored through formal talks, poster sessions, and interactive and intensive scientific discussion sessions. The sessions are organized in different themes and are all held in an intimate setting with a limited number of participants.

This meeting includes outstanding researchers from around the world presenting diverse, cutting edge and forward looking research directed towards a fundamental understanding of the mechanisms of TGF-β family signaling: how these factors coordinate developmental processes, how aberrations in this signaling pathway lead to developmental abnormalities and human disease pathologies, and how this knowledge may come to be applied in the clinic.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
2. FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
3. FASEB SRC announces conference registration open for: Histone Deacetylases, Sirtuins, and Reversible Acetylation in Signaling and Disease
4. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
5. FASEB SRC announces conference registration open for: Signal Transduction in the Immune System
6. FASEB SRC announces conference registration open for: Biology of Cilia and Flagella
7. FASEB SRC announces conference registration open for: Arf and Rab Family G Proteins
8. FASEB SRC announces conference: Glucose transport -- Gateway for Metabolic Systems Biology
9. FASEB SRC announces conference: Mitochondrial Assembly & Dynamics in Health, Disease & Aging
10. FASEB SRC announces: Molecular Mechanisms & Physiological Consequences of Protein Aggregation
11. FASEB SRC announces conference registration open for: Neural Mechanisms in Cardiovascular Regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology: